![]() ![]() We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. is the world's leading source for international market research reports and market data. ![]() Top 10 COVID-19 Vendors and Global Market Share, by Vendor (Abbott, bioMerieux, Danaher, Hologic, PerkinElmer, Qiagen, QuidelOrtho, Roche, Siemens, ThermoFisher, Others), 2022įor more information about this report visit.COVID-19 Testing Market by Country, Estimated 2022 ($M).Estimated Global COVID-19 Testing Market by Region, 2020-2022.Global COVID-19 IVD Market by Test Method, 2020-2022 and Forecast Through 2027 ($MN).Global Rapid-based COVID-19 Testing Market, Distribution of Sales by Segment (Immunoassay, Molecular), 2022-2027 ($MN).Global Lab-based COVID-19 Testing Market, Distribution of Sales by Segment (Immunoassay, Molecular), 2022-2027 ($MN).Global COVID-19 IVD Market by Test Site, 2020-2022 and Forecast Through 2027 ($MN).Global COVID-19 Testing by Test Site (Laboratory, Rapid/Near Patient) Sales by Segment, 2022-2027.Global IVD Market, Distribution by Performance Segment (COVID-19 Assays and Instruments, Excluding COVID-19 Assays and Instruments), 2022 (%).Global IVD Market (COVID-19 Assays and Instruments, Excluding COVID-19 Assays and Instruments), 2019-2022, ($MN).Global COVID-19 Testing (Immunoassay, Molecular, Rapid) Sales, by Segment, 2022-2027 ($MN).Molecular COVID-19 Vendor Market Share, by Vendor (Abbott, bioMerieux, Cepheid-Danaher, Hologic, Orasure Technologies, PerkinElmer, Qiagen, QuidelOrtho, Roche, ThermoFisher, Others), 2022 (%)Ĭhapter 6: Total COVID-19 Testing Market Summary.Selected Molecular EUA Tests for COVID-19.Immunoassay COVID-19 Vendor Market Share, by Vendor (Abbott, Beckman Coulter-Danaher, Becton Dickson, Diasorin, Fujirebio Diagnostics, PerkinElmer, QuidelOrtho, Roche, Siemens, ThermoFisher, Others), 2022 (%).Enzyme-linked Immunosorbent Assay (ELISA).EUAs and Public Health Emergency Expiration.At-Home COVID-19 Test Distribution of Sales, by Vendor (Abbott Diagnostics, Becton Dickinson, OraSure Technologies, Quidel, Siemens Healthineers, Others).Total Cases for Select Countries with Uptick in Cases, by Country, April 2023 Country-Level COVID-19 Cumulative Diagnostic Tests Administered, by Country Through April 11, 2023.Country-Level COVID-19 Cumulative Cases Through April 11, 2023.Coronavirus (COVID-19) 7-Day Case Snapshot Global by CountryĬoronavirus (COVID-19) Cumulative Cases and 7-Day Cases by WHO Region ( Africa, Americas, Eastern Mediterranean, Europe, South-East Asia, West Pacific).Key Issues and Trends Affecting the Market.Global COVID-19 Market by Key Segment (Molecular, Immunoassay), 2020-2027.Global COVID-19 Testing (Immunoassay, Molecular, Rapid) Sales by Segment, 2022-2027.Ltd (Shenzhen New Industries Biomedical Engineering Co) Some of the key topics and trends explored include: Ortho Clinical Diagnostics is now QuidelOrtho, transforming the power of diagnostics into a healthier future for all Learn More EDUCATION New Lab2Life quarterly newsletter sign up now and stay informed DIAGNOSTICS Introducing new ISXM capabilities. The report includes an analysis and profiles of key companies competing in this industry, including a breakout of the top competitors in the COVID-19 testing market based on 2022 manufacturer revenues. The forecasted market analysis through 2027 was largely based on demographic trends, new developments, the trajectory of COVID-19 and its variants, innovative technology and global use. Regional breakdowns are surveyed for North America, Europe, Asia-Pacific, and the Rest of the World. Data are provided for 20 with compound annual growth rates (CAGRs) for 20.Ĭompetitive analysis is provided for the top ten participants in the market. the CCP) and biochemists have the power and technology to manipulate RNA/DNA, and thereby control populations and economic activity- all with little traceability or accountability (compared to other weapon systems).All market data pertains to the world market at the manufacturers' level. This sort of thing will happen again, maybe on a regular basis, now that governments (esp. 'Two weeks to slow the spread' already became 2 years. (And God help us.) Rapid testing will soon become much more prevalent among consumers and providers (and the military), and that will extend well beyond Covid. Viral diagnostics appear to be a key part of the burgeoning global biodefense industry. The targets for QDEL should reflect not only the upcoming cash inflows from their 7x24 production line scale-up, supporting the 500M rapid tests Biden announced on Tuesday and a surge in demand from consumers and organizations as testing becomes the primary countermeasure to Covid spread but also upcoming revenues from Quidel's new Savanna and other product lines. Then there will be a more meaningful way to value the future of OCDX stock as well. Hopefully we will soon see more analyst coverage and price targets for QDEL - now that the combined company would be one of the top 7 medical diagnostics companies in the world. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |